메뉴 건너뛰기




Volumn , Issue APRIL, 2010, Pages 51-53

A novel sustainedrelease intravitreal drug delivery system for retinal vascular disease: Results with a liquid containing triamcinolone were promising in phase 1 trial in RVO

Author keywords

[No Author keywords available]

Indexed keywords


EID: 79952990684     PISSN: None     EISSN: 18250572     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (8)

References (8)
  • 1
    • 16844375997 scopus 로고    scopus 로고
    • Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration. 2-year results of a randomized clinical trial
    • Visudyne in Minimally Classic Choroidal Neovascularization Study Group
    • Visudyne in Minimally Classic Choroidal Neovascularization Study Group. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration. 2-year results of a randomized clinical trial. Arch Ophthalmol. 2005;123:448-457.
    • (2005) Arch Ophthalmol , vol.123 , pp. 448-457
  • 2
    • 11144239923 scopus 로고    scopus 로고
    • VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular agerelated macular degeneration
    • Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR. VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular agerelated macular degeneration. N Engl J Med. 2004;351(27):2805-2816.
    • (2004) N Engl J Med , vol.351 , Issue.27 , pp. 2805-2816
    • Gragoudas, E.S.1    Adamis, A.P.2    Cunningham Jr., E.T.3    Feinsod, M.4    Guyer, D.R.5
  • 3
    • 33749445317 scopus 로고    scopus 로고
    • Ranibizumab for neovascular age-related macular degeneration
    • Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419-31.
    • (2006) N Engl J Med , vol.355 , Issue.14 , pp. 1419-1431
    • Rosenfeld, P.J.1    Brown, D.M.2    Heier, J.S.3
  • 4
    • 33749451356 scopus 로고    scopus 로고
    • ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration
    • Brown DM, Kaiser PK, Michels M, et al; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432-1442.
    • (2006) N Engl J Med , vol.355 , Issue.14 , pp. 1432-1442
    • Brown, D.M.1    Kaiser, P.K.2    Michels, M.3
  • 7
    • 82255170485 scopus 로고    scopus 로고
    • Verisome Technology Overview
    • Accessed April 2
    • Verisome Technology Overview. Icon Bioscience Inc. Web site. http://iconbioscience.com/Technology-Overview.html. Accessed April 2, 2010.
    • (2010) Icon Bioscience Inc. Web Site


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.